MHRA reminds prescribers of psychiatric risks associated with isotretinoin

Patients receiving systemic isotretinoin (Roaccutane) for severe acne should be monitored for depression, anxiety and suicidal ideation.

by
A repeated course of oral isotretinoin should only be considered after at least 8 weeks and if there is a definite relapse. SCIENCE PHOTO LIBRARY
A repeated course of oral isotretinoin should only be considered after at least 8 weeks and if there is a definite relapse. SCIENCE PHOTO LIBRARY

To continue enjoying this article, please sign in. You can register for free for limited further access, or subscribe now for full access to all our content.

Sign In

Trouble signing in?

Reset password: Click here

Need help? Email us

Register

FREE

  • Limited free articles a month 
  • Free email bulletins

Register Now

Subscribe now

Benefits include:

  • Full site access
  • Subscriber exclusive content
  • Exclusive bulletins

Choose a package